Updates to the US Food and Drug Administration Regulations for Mifepristone: Implications for Clinical Practice and Access to Abortion-Reference-Cited by-同舟云学术

Updates to the US Food and Drug Administration Regulations for Mifepristone: Implications for Clinical Practice and Access to Abortion

Published:2017-05 Issue:3 Volume:62 Page:348-352
ISSN:1526-9523
Container-title:Journal of Midwifery & Women's Health
language:en
Short-container-title:Journal of Midwifery & Women's Health

Author:

Simmonds Katherine E.,Beal Margaret W.,Eagen-Torkko Meghan K.

Publisher

Wiley

Subject

Maternity and Midwifery,Obstetrics and Gynaecology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jmwh.12636/fullpdf

Reference17 articles.

1. Clinical uses of mifepristone: an update for women's health practitioners;Beal;J Midwifery Womens Health,2002

2. Centers for Disease Control and Prevention (CDC). Abortion surveillance-United States, 2012;Pazol;MMWR Surveill Summ,2015

3. Abortion surveillance-United States, 2013;Jatlaoui;MMWR Surveill Summ,2016

4. Food and Drug Administration (FDA) Historical information on mifepristone (Mifeprex) http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationxforPatientsandProviders/ucm111334.htm 2016

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of Postabortion Complications for the Emergency Medicine Clinician;Annals of Emergency Medicine;2021-02

2. The role of nurses and midwives in the provision of abortion care: A scoping review;Journal of Clinical Nursing;2020-05

3. Expanded Practice in Midwifery: Designing, Implementing, and Maintaining Programs;Journal of Midwifery & Women's Health;2019-07-19

4. Quantity over quality-Findings from a systematic review and environmental scan of patient decision aids on early abortion methods;Health Expectations;2017-09-07

5. The Hallmarks of Midwifery Connect This Diverse Pharmacology Continuing Education Theme Issue;Journal of Midwifery & Women's Health;2017-05